Case number 2017-2498
Enzo Life Sciences, Inc. v. Roche Molecular Systems, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 23, 2021 | 0 | ENZO LIFE SCIENCES, INC. v. ROCHE MOLECULAR SYSTEMS, INC. [OPINION - PRECEDENTIAL] [precedential] (0) |
| Mar 30, 2020 | 34 | The petition for writ of certiorari, [19-1073], filed on 02/26/2020, was Denied on 03/30/2020. [682816] [JAB] [Entered: 03/30/2020 03:56 PM] (1) |
| Mar 3, 2020 | 33 | Petition for writ of Certiorari filed on 02/26/2020, and placed on the docket 03/02/2020, in the Supreme Court of the United States. Supreme Court #: 19-1073, Enzo Life Sciences, Inc. v. Roche Molecular Systems, Inc., et al. [675941] [JAB] [Entered: 03/03/2020 03:52 PM] (1) |
| Jan 27, 2020 | 32 | Notice from the Supreme Court of the United States: The application for an extension of time within which to file a petition for a writ of certiorari in the above-entitled case has been presented to The Chief Justice, who on January 17, 2020, extended the time to and including February 26, 2020. [666986] [JAB] [Entered: 01/29/2020 01:31 PM] (3) |
| Nov 5, 2019 | 31 | Mandate issued to the United States District Court for the District of Delaware. Service as of this date by the Clerk of Court. [646933] [17-2498, 17-2499, 17-2545, 17-2546] [JAB] [Entered: 11/05/2019 01:04 PM] (2) |
| Oct 29, 2019 | 30 | ORDER filed denying [23] petition for panel rehearing filed by Enzo Life Sciences, Inc.; denying [23] petition for en banc rehearing filed by Enzo Life Sciences, Inc. By: En Banc (Per Curiam). Service as of this date by the Clerk of Court. [645418] [JAB] [Entered: 10/29/2019 10:38 AM] (2) |
| Oct 15, 2019 | 29 | 18 paper copies of the response [28] received from Appellees Abbott Laboratories, Abbott Molecular, Inc., et al. [642211] [MJL] [Entered: 10/15/2019 01:40 PM] (0) |
| Oct 11, 2019 | 28 | RESPONSE of Appellees Abbott Laboratories, Abbott Molecular, Inc., Becton Dickinson Diagnostics Inc., Becton, Dickinson and Company, GeneOhm Sciences Inc., Roche Diagnostics Corporation, Roche Diagnostics Operations, Inc., Roche Molecular Systems, Inc. and Roche NimbleGen, Inc. to the petition for panel rehearing [23] filed by Appellant Enzo Life Sciences, Inc., petition for en banc rehearing [23] filed by Appellant Enzo Life Sciences, Inc.. Service: 10/11/2019 by email. [641912] [17-2498] [Jason Wilcox] [Entered: 10/11/2019 03:09 PM] (33) |
| Sep 5, 2019 | 27 | ORDER filed granting motion to extend time to file response to rehearing/en banc [26] filed by Appellees Abbott Laboratories, Becton, Dickinson and Company, Abbott Molecular, Inc., Roche Diagnostics Corporation, Roche Diagnostics Operations, Inc., Roche Molecular Systems, Inc., Roche NimbleGen, Inc., Becton Dickinson Diagnostics Inc. and GeneOhm Sciences Inc. By: Per Curiam. Service as of this date by the Clerk of Court. [633261] [JAB] [Entered: 09/05/2019 10:29 AM] (2) |
| Aug 30, 2019 | 26 | MOTION of Appellees Abbott Laboratories, Abbott Molecular, Inc., Becton Dickinson Diagnostics Inc., Becton, Dickinson and Company, GeneOhm Sciences Inc., Roche Diagnostics Corporation, Roche Diagnostics Operations, Inc., Roche Molecular Systems, Inc. and Roche NimbleGen, Inc. to extend the time to file a response to the Combined Petition for Panel Rehearing and Rehearing En Banc until 10/11/2019 [Consent: unopposed]. Service: 08/30/2019 by email. [632513] [17-2498] [Jason Wilcox] [Entered: 08/30/2019 05:41 PM] (12) |
| Aug 28, 2019 | 25 | The court invites a response from Appellees Abbott Laboratories, Abbott Molecular, Inc., et al. to the combined petition for rehearing filed by Appellant in 17-2498. [631698] [MJL] [Entered: 08/28/2019 01:57 PM] (1) |
| Aug 7, 2019 | 24 | 18 paper copies of the combined petition for rehearing [23] received from Enzo Life Sciences, Inc. [626599] [MJL] [Entered: 08/07/2019 10:14 AM] (0) |
| Aug 5, 2019 | 23 | Petition for panel rehearing, for en banc rehearing filed by Appellant Enzo Life Sciences, Inc.. Service: 08/05/2019 by email. The paper copies of the petition must be filed within two business days (see Fed. Cir. R. 35(c)(4).The required paper copies should be received by the court on or before 08/07/2019 [626129] [17-2498] [Justin Wilcox] [Entered: 08/05/2019 08:51 PM] (43) |
| Jul 17, 2019 | 22 | ORDER filed granting motion to extend time to file petition for rehearing/en banc [21] filed by Appellant Enzo Life Sciences, Inc. Petition for Rehearing due on or before 08/05/2019. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [621688] [JAB] [Entered: 07/17/2019 12:52 PM] (2) |
| Jul 15, 2019 | 21 | MOTION of Appellant Enzo Life Sciences, Inc. to extend the time to file a Combined Petition for Panel Rehearing and Rehearing En Banc until 08/05/2019 [Consent: unopposed]. Service: 07/15/2019 by email. [621089] [17-2498] [Justin Wilcox] [Entered: 07/15/2019 04:23 PM] (6) |
| Jul 5, 2019 | 20 | ORDER filed unsealing the Precedential Opinion [16]. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [619148] [17-2498, 17-2499, 17-2545, 17-2546] [JAB] [Entered: 07/05/2019 09:42 AM] (2) |
| Jun 26, 2019 | 19 | RESPONSE of Appellant Enzo Life Sciences, Inc. and Appellees Roche Diagnostics Corporation, Roche Diagnostics Operations, Inc., Roche Molecular Systems, Inc., Roche NimbleGen, Inc., Becton Dickinson Diagnostics Inc., Becton, Dickinson and Company, GeneOhm Sciences Inc., Abbott Laboratories and Abbott Molecular, Inc. to the court order [17] , court order [17]. Service: 06/26/2019 by email. [617217] [17-2498] [Justin Wilcox] [Entered: 06/26/2019 05:05 PM] (5) |
| Jun 20, 2019 | 18 | JUDGMENT filed. AFFIRMED. Terminated on the merits after oral argument. COSTS: Costs taxed against Appellant(s). Mandate to issue in due course. For information regarding costs, petitions for rehearing, and petitions for writs of certiorari click here. [615728] [17-2498, 17-2499, 17-2545, 17-2546] [MJL] [Entered: 06/20/2019 09:56 AM] (2) |
| Jun 20, 2019 | 17 | ORDER filed to show cause. Joint response to the show cause order is due on or before 07/01/2019. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [615725] [17-2498, 17-2499, 17-2545, 17-2546] [MJL] [Entered: 06/20/2019 09:52 AM] (0) |
| Jun 20, 2019 | 16 | SEALED OPINION filed for the court by Prost, Chief Judge; Reyna, Circuit Judge and Wallach, Circuit Judge. Precedential Opinion. [615722] [17-2498, 17-2499, 17-2545, 17-2546]--[Edited 07/05/2019 by JAB to unseal opinion pursuant to court's order] [MJL] [Entered: 06/20/2019 09:45 AM] (16) |
| May 10, 2019 | 15 | **TEXT ONLY** ORDER granting motion to withdraw attorney Anuradha Sivaram [14] filed by Appellees Becton, Dickinson and Company, Roche Diagnostics Corporation, Roche Diagnostics Operations, Inc., Roche Molecular Systems, Inc., Roche NimbleGen, Inc., Becton Dickinson Diagnostics Inc. and GeneOhm Sciences Inc. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [606627] [JAB] [Entered: 05/10/2019 04:01 PM] (0) |
| May 10, 2019 | 14 | MOTION of Appellees Roche Molecular Systems, Inc., Roche Diagnostics Corporation, Roche Diagnostics Operations, Inc., Roche NimbleGen, Inc., Becton Dickinson Diagnostics Inc., Becton, Dickinson and Company and GeneOhm Sciences Inc. to withdraw counsel Anuradha Sivaram [Consent: unopposed]. Service: 05/10/2019 by email. [606584] [17-2498] [Anuradha Sivaram] [Entered: 05/10/2019 02:42 PM] (7) |
| Apr 26, 2019 | 13 | Official caption revised to reflect party aliases. The official caption is reflected on the electronic docket under the listing of the parties and counsel. Service as of this date by the Clerk of Court. [603185] [JAB] [Entered: 04/26/2019 11:35 AM] (0) |
| Apr 26, 2019 | 12 | NOTE TO FILE: FOR PRIOR ENTRIES SEE 17-2354. [603158] [PBC] [Entered: 04/26/2019 10:45 AM] (0) |
| Apr 26, 2019 | 11 | Note to file: The following cases are consolidated: 17-2498 (Lead) with 17-2499, -2545, -2546 (Members). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [603155] [17-2498, 17-2499, 17-2545, 17-2546] [PBC] [Entered: 04/26/2019 10:35 AM] (0) |
| Apr 26, 2019 | 10 | ORDER granting motion to dismiss 17-2354 and 17-2355 pursuant to FRAP 42(b) [602424-2] filed by Appellant Enzo Life Sciences, Inc.; issuing mandate in 17-2354, 17-2355. The revised official caption for 17-2498, -2499, -2545, -2546 is reflected in the order. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [603130] [17-2354, 17-2355, 17-2498, 17-2499, 17-2545, 17-2546] [PBC] [Entered: 04/26/2019 09:47 AM] (3) |
| Sep 8, 2017 | 9 | Note to file: The following cases are consolidated: 17-2354 (Lead) with 17-2498 and 17-2499 (Consolidated). FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [459642] [JB] [Entered: 09/08/2017 10:44 AM] (0) |
| Sep 8, 2017 | 8 | ORDER consolidating appeals (17-2354 (Lead) with 17-2498 and 17-2499 (Consolidated)). The appeals are consolidated. The revised official caption is reflected above. Enzo Life Sciences, Inc.'s opening brief is due no later than November 28, 2017. Service as of this date by Clerk of Court. [459641] [JB] [Entered: 09/08/2017 10:41 AM] (2) |
| Sep 6, 2017 | 7 | Docketing Statement for the Appellant Enzo Life Sciences, Inc.. Service: 09/06/2017 by email. [459121] [Peter Magic] [Entered: 09/06/2017 06:17 PM] (3) |
| Sep 6, 2017 | 6 | Certificate of Interest for the Appellant Enzo Life Sciences, Inc.. Service: 09/06/2017 by email. [459120] [Peter Magic] [Entered: 09/06/2017 06:13 PM] (2) |
| Sep 6, 2017 | 5 | Entry of appearance for Peter C. Magic as of counsel for Appellant Enzo Life Sciences, Inc.. Service: 09/06/2017 by email. [459119] [Peter Magic] [Entered: 09/06/2017 06:10 PM] (2) |
| Sep 6, 2017 | 4 | Entry of appearance for Justin P.D. Wilcox as of counsel for Appellant Enzo Life Sciences, Inc.. Service: 09/06/2017 by email. [459118] [Justin Wilcox] [Entered: 09/06/2017 06:05 PM] (2) |
| Sep 6, 2017 | 3 | Entry of appearance for John M. Desmarais as of counsel for Appellant Enzo Life Sciences, Inc.. Service: 09/06/2017 by email. [459117] [John Desmarais] [Entered: 09/06/2017 05:59 PM] (2) |
| Sep 6, 2017 | 2 | Entry of appearance for Michael P. Stadnick as principal counsel for Appellant Enzo Life Sciences, Inc.. Service: 09/06/2017 by email. [459116] [Michael Stadnick] [Entered: 09/06/2017 05:55 PM] (2) |
| Aug 29, 2017 | 1 | Appeal docketed. Received: 08/23/2017. [457383]Entry of Appearance due 09/12/2017. Certificate of Interest is due on 09/12/2017. Docketing Statement due 09/12/2017. Appellant/Petitioner's brief is due 10/30/2017. [JB] [Entered: 08/29/2017 01:54 PM] (54) |
